Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Farde

Showing results (201-210 of 207) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 207 results.
European Journal of Nuclear Medicine|February 24, 2001
SPET imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNPK Nobuhara, L Farde, C Halldin, et al.
Nuclear Medicine and Biology|September 3, 1999
PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporterJ Helfenbein, J Sandell, C Halldin, et al.
Psychopharmacology|May 2, 2000
Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's diseaseK Nobuhara, C Halldin, H Hall, et al.
Nuclear Medicine and Biology|June 10, 1998
Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modellingS Osman, C Lundkvist, V W Pike, et al.
European Journal of Nuclear Medicine|May 30, 1998
[carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivoV W Pike, C Halldin, J A McCarron, et al.
Nuclear Medicine and Biology|July 1, 1996
Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PETS Osman, C Lundkvist, V W Pike, et al.
European Journal of Nuclear Medicine|June 18, 1998
Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imagingJ T Kuikka, J L Baulieu, J Hiltunen, et al.
Pageof 21

Showing results (201-210 of 207) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 207 results.
European Journal of Nuclear Medicine|February 24, 2001
SPET imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNPK Nobuhara, L Farde, C Halldin, et al.
Nuclear Medicine and Biology|September 3, 1999
PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporterJ Helfenbein, J Sandell, C Halldin, et al.
Psychopharmacology|May 2, 2000
Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's diseaseK Nobuhara, C Halldin, H Hall, et al.
Nuclear Medicine and Biology|June 10, 1998
Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modellingS Osman, C Lundkvist, V W Pike, et al.
European Journal of Nuclear Medicine|May 30, 1998
[carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivoV W Pike, C Halldin, J A McCarron, et al.
Nuclear Medicine and Biology|July 1, 1996
Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PETS Osman, C Lundkvist, V W Pike, et al.
European Journal of Nuclear Medicine|June 18, 1998
Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imagingJ T Kuikka, J L Baulieu, J Hiltunen, et al.
Pageof 21